Course options

There are other course options available which may have a different vacancy status or entry requirements – view the full list of options

Make sure you check on the university, college or conservatoire website for any updates about course changes as a result of COVID-19.

Course summary

Why study this course? London Met’s Cancer Pharmacology master's course explores the nature of cancer at the systems, cellular and molecular levels, and focuses on the drugs which are used to treat different cancers and how they work. By the end of the MSc, you will have developed a deep understanding of how chemotherapeutic agents are used to target and kill cancer cells as part of a central strategy in the treatment of cancers. More about this course With worldwide cancer rates increasing and expected to reach 22 million new cases per year by 2030, this postgraduate course introduces you to how radiotherapy, surgery and chemotherapy have a vital role to play in prolonging the lives of patients. We’ll provide you with an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, and of how drug therapies are evolving. You’ll also review the biology of cancer with respect to genetics, pathological considerations and the molecular changes within cells which are associated with the progression of the disease. You'll be taught by staff who are experienced researchers in areas such as cancer biology, immunology, genetics and bioinformatics. They will help you learn how to collect, analyse, interpret and understand scientific data you must make use of in the cancer pharmacology field. This ensures you’ll not only improve your intellectual knowledge but your practical skills as well. Your laboratory-based project will be conducted in our £30 million Science Centre. This includes access to extensive cell culture facilities, electrophoresis equipment, polymerase chain reaction (PCR) cyclers and high performance liquid chromatography (HPLC) instrumentation. Overall, this programme of advanced study provides you with the necessary skills, knowledge and understanding for you to pursue a career in anti-cancer drug development.

Modules

Example Core modules include: Molecular Oncology Cancer Pharmacology Cancer Diagnosis and Treatment Molecular Genetics Scientific Frameworks for Research Research Project Example Optional modules include: Drug Discovery Technology Advanced Drug Formulation Technologies Bioinformatics Molecular Modelling

Assessment method

Assessment is a combination of coursework, which includes tests and essays, the research project and its oral defence and examination.


Entry requirements

You will be required to have a lower second class (2.2) UK first degree (or equivalent) in an appropriate subject, for example pharmacology, biomedical science, biological science or medical genetics. All applicants must be able to demonstrate proficiency in the English language.


Fees and funding

Tuition fees

England £10500 Whole course
Northern Ireland £10500 Whole course
Scotland £10500 Whole course
Wales £10500 Whole course
EU £18150 Whole course
International £18150 Whole course
Channel Islands £18150 Whole course
Republic of Ireland £18150 Whole course

Additional fee information

Please note, in addition to the tuition fee there may be additional costs for things like equipment, materials, printing, textbooks, trips or professional body fees. Additionally, there may be other activities that are not formally part of your course and not required to complete your course, but which you may find helpful (for example, optional field trips). The costs of these are additional to your tuition fee and the fees set out above and will be notified when the activity is being arranged.
Cancer Pharmacology at London Metropolitan University - UCAS